ReutersReuters

Dermata Therapeutics terminates license agreement with Villani dated March 31, 2017, says in SEC Filing

RefinitivLess than 1 min read

Dermata Therapeutics Inc DRMA:

  • DERMATA THERAPEUTICS INC - ON NOV 17, TERMINATES LICENSE AGREEMENT WITH VILLANI DATED MARCH 31, 2017 - SEC FILING

  • DERMATA THERAPEUTICS INC - TERMINATION LINKED TO STRATEGIC SHIFT TO OTC SKIN CARE - SEC FILING

  • DERMATA THERAPEUTICS : VILLANI WILL NOT BE ENTITLED TO RECEIVE ANY FURTHER MILESTONES OR OTHER PAYMENTS DUE AFTER TERMINATION DATE

Login or create a forever free account to read this news